168 related articles for article (PubMed ID: 31698611)
21. [N-myc oncogene amplification in tumors of the sympathetic nervous system: preliminary study of methods and clinico-pathologic correlations].
Dahbiová R; Kodet R; Soukup J; Kavan P; Smelhaus V; Koutecký J
Cesk Patol; 1997 Aug; 33(3):83-8. PubMed ID: 9471397
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis.
Fagone P; Nicoletti F; Vecchio GM; Parenti R; Magro G
Acta Histochem; 2015 Oct; 117(8):820-3. PubMed ID: 26510683
[TBL] [Abstract][Full Text] [Related]
23. Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours.
Barclay SF; Rand CM; Borch LA; Nguyen L; Gray PA; Gibson WT; Wilson RJ; Gordon PM; Aung Z; Berry-Kravis EM; Ize-Ludlow D; Weese-Mayer DE; Bech-Hansen NT
Orphanet J Rare Dis; 2015 Aug; 10():103. PubMed ID: 26302956
[TBL] [Abstract][Full Text] [Related]
24. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
25. A Preliminary Study on the Application of Contrast-Enhanced Ultrasonography in Children With Peripheral Neuroblastic Tumors.
Wang T; Han D; Xiao H; Yang H; Chen JY; Tang Y
Ultrasound Med Biol; 2024 Jun; 50(6):954-960. PubMed ID: 38575414
[TBL] [Abstract][Full Text] [Related]
26. Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.
Banelli B; Bonassi S; Casciano I; Mazzocco K; Di Vinci A; Scaruffi P; Brigati C; Allemanni G; Borzì L; Tonini GP; Romani M
Int J Cancer; 2010 Feb; 126(3):656-68. PubMed ID: 19626586
[TBL] [Abstract][Full Text] [Related]
27. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
[TBL] [Abstract][Full Text] [Related]
28. Clinical and surgical outcome differences on the basis of pathology category in cervical neuroblastic tumors.
Liu Q; Wang S; Chu P; Sun J; Jin Y; Guo Y; Ma X; He L; Su Y; Zhang J; Peng Y; Li Y; Zhang X; Sun N; Liu Z; Ni X
J Pediatr Surg; 2022 Dec; 57(12):926-933. PubMed ID: 35961818
[TBL] [Abstract][Full Text] [Related]
29. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
30. High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.
Tabyaoui I; Tahiri-Jouti N; Serhier Z; El Maani K; Cherkaoui S; Al Zemmouri M; Othmani MB; Zamiati S
Diagn Mol Pathol; 2013 Jun; 22(2):112-8. PubMed ID: 23628823
[TBL] [Abstract][Full Text] [Related]
31. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.
Coco S; Defferrari R; Scaruffi P; Cavazzana A; Di Cristofano C; Longo L; Mazzocco K; Perri P; Gambini C; Moretti S; Bonassi S; Tonini GP
J Pathol; 2005 Nov; 207(3):346-57. PubMed ID: 16178058
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
33. Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach.
Choi JH; Ro JY
Semin Diagn Pathol; 2022 Mar; 39(2):120-130. PubMed ID: 34167847
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic features of peripheral neuroblastic tumors].
Yang BF; Fu LB; He LJ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
[TBL] [Abstract][Full Text] [Related]
35. [Pathology of peripheral neuroblastic tumors].
Wang L; He LJ; Shimada H
Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):283-8. PubMed ID: 22800533
[No Abstract] [Full Text] [Related]
36. Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma.
He WG; Yan Y; Tang W; Cai R; Ren G
Oncotarget; 2017 Jun; 8(23):37730-37739. PubMed ID: 28465480
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma.
Kubota M; Suita S; Tajiri T; Shono K; Fujii Y
J Pediatr Surg; 2000 Jan; 35(1):92-5. PubMed ID: 10646782
[TBL] [Abstract][Full Text] [Related]
38. Metastatic neuroblastoma with ganglioneuromatous differentiation and mandibular involvement.
Bhattacharyya I; Williamson A; Cohen DM; Bever JL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Nov; 88(5):586-92. PubMed ID: 10556754
[TBL] [Abstract][Full Text] [Related]
39. Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group.
Joshi VV; Cantor AB; Altshuler G; Cohen LJ; Larkin EW; Shuster JJ; Rao PV; Holbrook CT; Hayes FA; Castleberry RP
Arch Pathol Lab Med; 1996 Sep; 120(9):859-65. PubMed ID: 9140292
[TBL] [Abstract][Full Text] [Related]
40. Frequency of ALK and GD2 Expression in Neuroblastoma.
Aygün Z; Batur Ş; Emre Ş; Celkan T; Özman O; Comunoglu N
Fetal Pediatr Pathol; 2019 Aug; 38(4):326-334. PubMed ID: 30955398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]